References
- Acan NL, Tezcan EF. (1989). Sheep brain glutathione reductase: Purifi cation and general properties. FEBS Lett 250: 72-74.
- Aldini G, Vistoli G, Stefek M, Chondrogianni N, Grune T, Sereikaite J, Sadowska-Bartosz I, Bartosz G. (2013). Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products. Free Radic Res 47 Suppl 1: 93-137.
- Betke K, Brewer GJ, Kirkman HN, Luzzato L, Motulsky AG, Ramot B, Siniscalco M. (1967). Standardized method for G-6-PD assay of haemolysates. WHO Tech Rep Ser 366: 30-32.
- Bolańos JP, Almeida A. (2010). The pentose-phosphate pathway in neuronal survival against nitrosative stress. IUBMB Life 62: 14-18.
- Bradford MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72: 248-254.
- Broskova Z, Sotnikova R, Nedelcevova J, Bagi Z. (2013). Eff ect of a novel stobadine derivative on isolated rat arteries. Interdiscip Toxicol 6: 63-66.
- Cencioni C, Spallotta F, Martelli F, Valente S, Mai A, Zeiher AM, Gaetano C. (2013). Oxidative stress and epigenetic regulation in ageing and age-related diseases. Int J Mol Sci 14: 17643-17663.10.3390/ijms140917643
- Chandran R, Parimelazhagan T, Shanmugam S, Thankarajan S. (2016). Antidiabetic activity of Syzygium calophyllifolium in Streptozotocin-Nicotinamide induced Type-2 diabetic rats. Biomed Pharmacother 82: 547-554.10.1016/j.biopha.2016.05.036
- Chandrasena LG, De Silva LD, De Silva KI, Dissanayaka P, Peiris H. (2008). Changes in erythrocyte glucose-6-phosphate dehydrogenase (G6PD) and reduced glutathione (GSH) activities in the development of senile and diabetic cataracts. Southeast Asian J Trop Med Public Health 39: 731-736.
- Drimal J, Knezl V, Navarova J, Nedelcevova J, Paulovicova E, Sotnikova R, Snirc V, Drimal D. (2008). Role of infl ammatory cytokines and chemoattractants in the rat model of streptozotocin-induced diabetic heart failure. Endocr Regul 42: 129-135.
- Gasparova Z, Stara V, Janega P, Navarova J, Sedlackova N, Mach M, Ujhazy E. (2014). Pyridoindole antioxidant-induced preservation of rat hippocampal pyramidal cell number linked with reduction of oxidative stress yet without infl uence on cognitive deterioration in Alzheimer-like neurodegeneration. Neuro Endocrinol Lett 35: 454-462.
- Gök M, Ulusu NN, Tarhan N, Tufan C, Ozansoy G, Arı N, Karasu C. (2016). Flaxseed Protects Against Diabetes-Induced Glucotoxicity by Modulating Pentose Phosphate Pathway and Glutathione-Dependent Enzyme Activities in Rats. J Diet Suppl 13: 339-351.
- Gupte RS, Floyd BC, Kozicky M, George S, Ungvari ZI, Neito V, Wolin MS, Gupte SA. (2009). Synergistic activation of glucose-6-phosphate dehydrogenase and NAD(P)H oxidase by Src kinase elevates superoxide in type 2 diabetic, Zucker fa/fa, rat liver. Free Radic Biol Med 47: 219-228.
- Habig WH, Jakoby WB. (1981). Glutathione transferase (human placenta). Methods Enzymol 77: 218-231.
- Karasu C. (2010). Glycoxidative stress and cardiovascular complications in experimentally- induced diabetes: eff ects of antioxidant treatment. Open Cardiovasc Med J 4: 240-256.
- Koçak G, Aktan F, Canbolat O, Ozoğul C, Elbeğ S, Yildizoglu-Ari N, Karasu C; ADIC Study Group-Antioxidants in Diabetes-Induced Complications. (2000). Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes. Diabetes Nutr Metab 13: 308-318.
- Kyselova Z, Gajdosik A, Gajdosikova A, Ulicna O, Mihalova D, Karasu C, Stefek M. (2005). Eff ect of the pyridoindole antioxidant stobadine on development of experimental diabetic cataract and on lens protein oxidation in rats: comparison with vitamin E and BHT. Mol Vis 11: 56-65.
- Matsui R, Xu S, Maitland KA, Hayes A, Leopold JA, Handy DE, Loscalzo J, Cohen RA. (2005). Glucose-6 phosphate dehydrogenase defi ciency decreases the vascular response to angiotensin II. Circulation 112: 257-263.
- Maurya PK, Kumar P, Chandra P. (2016). Age-dependent detection of erythrocytes glucose-6-phosphate dehydrogenase and its correlation with oxidative stress. Arch Physiol Biochem 122: 61-66.
- Nobrega-Pereira S, Fernandez-Marcos PJ, Brioche T, Gomez-Cabrera MC, Salvador-Pascual A, Flores JM, Vina J, Serrano M. (2016). G6PD protects from oxidative damage and improves healthspan in mice. Nat Commun 7: 10894.
- Ozdemir S, Tandogan B, Ulusu NN, Turan B. (2009). Angiotensin II receptor blockage prevents diabetes-induced oxidative damage in rat heart. Folia Biol (Praha) 55: 11-16.
- Pahwa S, Sharma R, Singh B. (2017). Role of Glutathione S-Transferase in Coronary Artery Disease Patients with and Without Type 2 Diabetes Mellitus. J Clin Diagn Res 11: BC05-BC08.
- Panigrahy SK, Bhatt R, Kumar A. (2017). Reactive oxygen species: sources, consequences and targeted therapy in type 2 diabetes. J Drug Target 25: 93-101.10.1080/1061186X.2016.1207650
- Park YJ, Choe SS, Sohn JH, Kim JB. (2017). The role of glucose-6-phosphate dehydrogenase in adipose tissue infl ammation in obesity. Adipocyte 8: 1-7.
- Pearse BMF, Rosemeyer MA. (1975). 6-Phosphogluconate dehydrogenase from human erythrocytes. Methods Enzymol 41: 220-226.
- Peiró C, Romacho T, Azcutia V, Villalobos L, Fernandez E, Bolanos JP, Moncada S, Sanchez-Ferrer CF. (2016). Infl ammation, glucose, and vascular cell damage: the role of the pentose phosphate pathway. Cardiovasc Diabetol 15: 82.10.1186/s12933-016-0397-2
- Raza H, John A, Howarth FC. (2012). Alterations in glutathione redox metabolism, oxidative stress, and mitochondrial function in the left ventricle of elderly Zucker diabetic fatty rat heart. Int J Mol Sci. 13: 16241-16254.10.3390/ijms131216241
- Sahoo S, Meijles DN, Pagano PJ. (2016). NADPH oxidases: key modulators in aging and age-related cardiovascular diseases? Clin Sci 130: 317-335.
- Sakul A, Cumaoğlu A, Aydin E, Ari N, Dilsiz N, Karasu C. (2013) Age- and diabetes- induced regulation of oxidative protein modifi cation in rat brain and peripheral tissues: consequences of treatment with antioxidant pyridoindole. Exp Gerontol 48: 476-484.10.1016/j.exger.2013.02.028
- Shakeel M. (2015). Recent advances in understanding the role of oxidative stress in diabetic neuropathy. Diabetes Metab Syndr 9: 373-378.
- Stanton RC. (2012). Glucose-6-phosphate dehydrogenase, NADPH, and cell survival. IUBMB Life 64: 362-369.10.1002/iub.1017
- Stefek M, Karasu C. (2011). Eye lens in aging and diabetes: eff ect of quercetin. Rejuvenation Res 14: 525-534.
- Stefek M, Milackova I, Juskova-Karasova M, Snirc V. (2013). Antioxidant action of the hexahydropyridoindole SMe1EC2 in the cellular system of isolated red blood cells in vitro. Redox Rep 18: 71-75.10.1179/1351000213Y.0000000043
- Tandogan B, Guvenc A, Calış İ, Ulusu NN. (2011). In vitro eff ects of compounds isolated from Sideritis brevibracteata on bovine kidney cortex glutathione reductase. Acta Biochim Pol 58: 471-475.
- Ulusu NN, Ozbey G, Tandogan B, Gunes A, Durakoglugil DB, Karasu C, Uluoglu C, Zengil H. (2005). Circadian variations in the activities of 6-phosphogluconate dehydrogenase and glucose-6-phosphate dehydrogenase in the liver of control and streptozotocin-induced diabetic rats. Chronobiol Int 22: 667-677.10.1080/07420520500179886
- Ulusu NN, Sahilli M, Avci A, Canbolat O, Ozansoy G, Ari N, Bali M, Stefek M, Stolc S, Gajdosik A, Karasu C. (2003). Pentose phosphate pathway, glutathione- dependent enzymes and antioxidant defense during oxidative stress in diabetic rodent brain and peripheral organs: eff ects of stobadine and vitamin E. Neurochem Res 28: 815-823.10.1023/A:1023202805255
- Ulusu NN. (2015). Glucose-6-phosphate dehydrogenase defi ciency and Alzheimer’s disease: Partners in crime? The hypothesis. Med Hypotheses 85: 219-223.
- Vyskočilová E, Szotakova B, Skalova L, Bartikova H, Hlavačova J, Boušova I. (2013). Age-related changes in hepatic activity and expression of detoxifi - cation enzymes in male rats. Biomed Res Int 2013: 408573.
- Warrington JS, Greenblatt DJ, von Moltke LL. (2004). Age-related diff erences in CYP3A expression and activity in the rat liver, intestine, and kidney. J Pharmacol Exp Ther 309: 720-729.
- Yang HC, Wu YH, Liu HY, Stern A, Chiu DT. (2016). What has passed is prolog: new cellular and physiological roles of G6PD. Free Radic Res 50: 1047-1064.
- Yun KU, Oh SJ, Oh JM, Kang KW, Myung CS, Song GY, Kim BH, Kim SK. (2010). Age-related changes in hepatic expression and activity of cytochrome P450 in male rats. Arch Toxicol 84: 939-946.
- Zhang Z, Liew CW, Handy DE, Zhang Y, Leopold JA, Hu J, Guo L, Kulkarni RN, Loscalzo J, Stanton RC. (2010). High glucose inhibits glucose-6-phosphate dehydrogenase, leading to increased oxidative stress and beta-cell apoptosis. FASEB J 24: 1497-1505.10.1096/fj.09-136572
- Zúrová-Nedelcevova J, Navarova J, Drabikova K, Jancinova V, Petrikova M, Bernatova I, Kristova V, Snirc V, Nosal’ova V, Sotnikova R. (2006). Participation of reactive oxygen species in diabetes-induced endothelial dysfunction. Neuro Endocrinol Lett 27 Suppl 2:168-171.